Literature DB >> 21798756

On the dual roles and polarized phenotypes of neutrophils in tumor development and progression.

H Piccard1, R J Muschel, G Opdenakker.   

Abstract

Inconsistencies plague our understanding of the role of neutrophils in cancer and the literature provides evidence for a duality in neutrophil activity on the outcome of cancer. Here, the different effects of neutrophils during the multiple subprocesses of cancer development and progression are overviewed, in order to gain insight into the features of both antitumoral and protumoral tumor-associated neutrophils (TAN). Neutrophils can counteract the progression of malignancies through tumor cytotoxicity, tumor rejection and enhancement of antitumoral immune memory. These cells have recently been phenotypically denominated N1 neutrophils. Recent studies indicate that cytokines, such as TGF-β and IFN-β, are involved in directing neutrophil polarization by the tumor microenvironment. With the opposite polarity, N2 neutrophils may be detrimental for the host and beneficial for tumor growth, invasion and metastasis, e.g. through proteolysis of extracellullar matrix components, promotion of angiogenesis and mediation of immunosuppression.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798756     DOI: 10.1016/j.critrevonc.2011.06.004

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  132 in total

1.  Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.

Authors:  Jennifer Vandooren; Benjamin Born; Inna Solomonov; Ewa Zajac; Radka Saldova; Michael Senske; Estefanía Ugarte-Berzal; Erik Martens; Philippe E Van den Steen; Jo Van Damme; Angeles Garcia-Pardo; Matheus Froeyen; Elena I Deryugina; James P Quigley; Søren K Moestrup; Pauline M Rudd; Irit Sagi; Ghislain Opdenakker
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

Review 2.  Neutrophils in the Tumor Microenvironment.

Authors:  Davalyn R Powell; Anna Huttenlocher
Journal:  Trends Immunol       Date:  2015-12-14       Impact factor: 16.687

3.  Cutting Edge: Helicobacter pylori Induces Nuclear Hypersegmentation and Subtype Differentiation of Human Neutrophils In Vitro.

Authors:  Laura C Whitmore; Megan N Weems; Lee-Ann H Allen
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

Review 4.  The multifaceted functions of neutrophils.

Authors:  Tanya N Mayadas; Xavier Cullere; Clifford A Lowell
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

5.  The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis.

Authors:  Courtney A Cohen; Amanda A Shea; C Lynn Heffron; Eva M Schmelz; Paul C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-10

Review 6.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

7.  Neutrophil elastase mediates acute pathogenesis and is a determinant of long-term behavioral recovery after traumatic injury to the immature brain.

Authors:  Bridgette D Semple; Alpa Trivedi; Kayleen Gimlin; Linda J Noble-Haeusslein
Journal:  Neurobiol Dis       Date:  2014-12-09       Impact factor: 5.996

8.  Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction.

Authors:  Pingping Hu; Zhaofei Pang; Hongchang Shen; Guanghui Wang; Haifeng Sun; Jiajun Du
Journal:  Tumour Biol       Date:  2014-12-07

9.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28

10.  Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans.

Authors:  Sara Massena; Gustaf Christoffersson; Evelina Vågesjö; Cédric Seignez; Karin Gustafsson; François Binet; Carmen Herrera Hidalgo; Antoine Giraud; Jalal Lomei; Simone Weström; Masabumi Shibuya; Lena Claesson-Welsh; Pär Gerwins; Michael Welsh; Johan Kreuger; Mia Phillipson
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.